Author: Stefani Kim

Frequency Therapeutics Receives $32 Million Funding for Drug to Treat Hearing Loss

Frequency Therapeutics announced the closing of a $32 million Series A financing for what it views as a whole new category of disease-modifying therapeutics, including regrowth of inner-ear hair cells, for a wide range of degenerative conditions. The funding round was led by CoBro Ventures. Additional participating investors included Morningside Ventures, Emigrant Capital Corp, Korean Investment Partnership, Alexandria Real Estate Equities, and other US and international investors.

Read More